Twin Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37M Sell
19,015
-37
-0.2% -$2.85K 0.18% 130
2025
Q4
$1.51M Sell
19,052
-2,745
-13% -$216K 0.19% 122
2025
Q3
$1.64M Sell
21,797
-514
-2% -$35.2K 0.21% 114
2025
Q2
$1.54M Buy
22,311
+10,795
+94% +$708K 0.16% 146
2025
Q1
$780K Sell
11,516
-128
-1% -$7.66K 0.09% 193
2024
Q4
$523K Sell
11,644
-23,585
-67% -$1.32M 0.06% 245
2024
Q3
$2.22M Buy
35,229
+2,550
+8% +$149K 0.25% 111
2024
Q2
$1.93M Buy
32,679
+173
+0.5% +$10.8K 0.23% 123
2024
Q1
$2.59M Sell
32,506
-2,156
-6% -$165K 0.32% 94
2023
Q4
$2.74M Buy
34,662
+5,335
+18% +$380K 0.36% 78
2023
Q3
$2.05M Sell
29,327
-2,537
-8% -$180K 0.29% 102
2023
Q2
$2.2M Buy
31,864
+2,416
+8% +$172K 0.29% 102
2023
Q1
$2.19M Sell
29,448
-3,798
-11% -$318K 0.3% 108
2022
Q4
$3.1M Sell
33,246
-1,175
-3% -$113K 0.4% 75
2022
Q3
$3.28M Sell
34,421
-420
-1% -$41.6K 0.44% 62
2022
Q2
$3.23M Sell
34,841
-657
-2% -$64.1K 0.41% 71
2022
Q1
$3.59M Buy
35,498
+1,410
+4% +$148K 0.39% 78
2021
Q4
$3.52M Sell
34,088
-3,576
-9% -$330K 0.35% 91
2021
Q3
$3.2M Sell
37,664
-3,710
-9% -$311K 0.33% 100
2021
Q2
$3.45M Sell
41,374
-89
-0.2% -$7.29K 0.32% 104
2021
Q1
$3.12M Sell
41,463
-5,140
-11% -$374K 0.31% 107
2020
Q4
$3.18M Sell
46,603
-2,386
-5% -$155K 0.29% 106
2020
Q3
$2.86M Sell
48,989
-757
-2% -$47.1K 0.26% 116
2020
Q2
$3.23M Sell
49,746
-15,986
-24% -$1.01M 0.31% 101
2020
Q1
$3.9M Sell
65,732
-294
-0.4% -$19.6K 0.42% 70
2019
Q4
$4.91M Sell
66,026
-56,668
-46% -$3.98M 0.41% 73
2019
Q3
$7.74M Sell
122,694
-3,088
-2% -$183K 0.56% 47
2019
Q2
$6.85M Sell
125,782
-56,683
-31% -$3.05M 0.48% 60
2019
Q1
$9.84M Buy
182,465
+1,462
+0.8% +$90.2K 0.48% 61
2018
Q4
$11.9M Buy
181,003
+66,273
+58% +$4.95M 0.67% 38
2018
Q3
$9.03M Buy
114,730
+6,200
+6% +$443K 0.42% 73
2018
Q2
$6.98M Buy
108,530
+730
+0.7% +$48.1K 0.35% 92
2018
Q1
$6.71M Sell
107,800
-4,440
-4% -$319K 0.35% 97
2017
Q4
$8.14M Buy
112,240
+1,780
+2% +$129K 0.4% 75
2017
Q3
$8.98M Buy
110,460
+54,020
+96% +$4.27M 0.47% 64
2017
Q2
$4.54M Buy
56,440
+1,820
+3% +$144K 0.27% 119
2017
Q1
$4.29M Buy
54,620
+7,510
+16% +$600K 0.27% 119
2016
Q4
$3.72M Sell
47,110
-40,944
-46% -$3.31M 0.24% 132
2016
Q3
$7.84M Buy
88,054
+9,790
+13% +$924K 0.52% 52
2016
Q2
$7.49M Sell
78,264
-12,700
-14% -$1.27M 0.56% 45
2016
Q1
$9.44M Sell
90,964
-4,890
-5% -$475K 0.73% 35
2015
Q4
$9.37M Buy
95,854
+7,760
+9% +$760K 0.77% 35
2015
Q3
$8.5M Sell
88,094
-4,490
-5% -$472K 0.81% 32
2015
Q2
$9.71M Sell
92,584
-4,550
-5% -$465K 0.87% 24
2015
Q1
$10M Buy
97,134
+8,080
+9% +$818K 0.88% 23
2014
Q4
$8.58M Buy
89,054
+6,360
+8% +$560K 0.82% 27
2014
Q3
$6.58M Buy
82,694
+170
+0.2% +$13.4K 0.67% 36
2014
Q2
$6.22M Buy
82,524
+3,460
+4% +$261K 0.63% 34
2014
Q1
$5.92M Buy
79,064
+440
+0.6% +$31.1K 0.62% 35
2013
Q4
$5.63M Sell
78,624
-9,350
-11% -$601K 0.6% 38
2013
Q3
$4.99M Sell
87,974
-7,140
-8% -$425K 0.53% 43
2013
Q2
$5.44M Buy
+95,114
New +$5.51M 0.58% 42

Other funds holding CVS

Twin Capital Management's CVS Position: Q1 2026 in Review

Twin Capital Management reduced its CVS Health (CVS) stake by 0.19% in Q1 2026, selling an estimated $2.85K and leaving 19,015 shares worth $1.37M. The position accounts for 0.18% of the portfolio, ranked #130.

Twin Capital Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $11.9M in Q4 2018. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Twin Capital Management held 19,015 shares of CVS Health worth $1.37M as of Q1 2026.
  • Twin Capital Management sold 37 CVS Health shares in Q1 2026, an estimated $2.85K.
  • CVS Health made up 0.18% of Twin Capital Management's portfolio in Q1 2026, its #130 holding.
  • Twin Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Twin Capital Management's CVS Health position peaked at $11.9M in Q4 2018.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Twin Capital Management's 13F filing for Q1 2026, filed 5 May 2026.